Development Development Development Development Development Development Development Development Development Development Development Development Development Development Development Development Development Development Development Development Development Development Development Development

Dosage Forms Dosage Forms Dosage Forms Dosage Forms Dosage Forms Dosage Forms Dosage Forms Dosage Forms Dosage Forms Dosage Forms

From the CEO

From the Editor

Front & Center

Global Perspectives

Inside Standards

Insider Solutions

Intellectual Property & Patents

Mergers and Acquisitions

Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing

Peer-Reviewed Research

PharmTech Talk

Quality Systems Quality Systems Quality Systems Quality Systems Quality Systems Quality Systems Quality Systems Quality Systems Quality Systems Quality Systems Quality Systems Quality Systems Quality Systems Quality Systems Quality Systems Quality Systems Quality Systems

Statistical Solutions

Therapeutic-Specific Areas

Troubleshooting

Viewpoints

Weighing Up Big Pharma

Spotlight -

Analytics

Dosage Forms

Drug Development

Manufacturing

Outsourcing

Quality Systems

Analytics Analytics Analytics Analytics Analytics Analytics Analytics Analytics Analytics Analytics Analytics Analytics Analytics Analytics

Best Practices

Bio/Pharma Business

Bio/Pharma and Brexit

COVID-19 Update

Conferences

Deals, Development and Manufacturing

Dosage Forms Dosage Forms Dosage Forms Dosage Forms Dosage Forms Dosage Forms Dosage Forms Dosage Forms Dosage Forms Dosage Forms

Intellectual Property & Patents

Mergers and Acquisitions

Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing Outsourcing

Peer-Reviewed Research

PharmTech Talk

Statistical Solutions

Therapeutic-Specific Areas

Troubleshooting

Viewpoints

Weighing Up Big Pharma

Mergers and Acquisitions

Latest News

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Avid Bioservices Acquired by GHO Capital Partners and Ampersand Capital Partners

By Susan Haigney

November 7th 2024

The merger agreement is valued at approximately $1.1 billion.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Merck Acquires Modifi Biosciences

By Susan Haigney

October 24th 2024

Merck is acquiring the Yale-spinout, which develops direct DNA modification-enabled cancer treatments.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

Phillips Medisize to Acquire Vectura, Expanding Inhalation Drug Delivery Capabilities

By Patrick Lavery

September 20th 2024

Vectura’s expertise in the field includes formulation and device development for dry powder inhalers and pressurized metered dose inhalers, among other products and services.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Completion of $3.2 Billion Morphic Acquisition Expands Lilly’s IBD Portfolio

By Feliza Mirasol

August 28th 2024

The completed acquisition of Morphic expands Lilly's immunology pipeline with Morphic's oral integrin therapies for treating inflammatory bowel disease.

Merck to Gain Investigational Bispecific Antibody in $1.3 Billion Curon Biopharmaceutical Deal

By Feliza Mirasol

August 22nd 2024

Merck, known as MSD outside of the United States and Canada, will gain CN201, a next-generation bispecific antibody, from Curon Biopharmaceutical in a deal potentially worth up to $1.3 billion.

...

13 14 15 16 17

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777